FRISINA, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 8.286
EU - Europa 7.941
AS - Asia 3.815
SA - Sud America 1.281
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 66
OC - Oceania 7
Totale 21.498
Nazione #
US - Stati Uniti d'America 8.050
RU - Federazione Russa 4.009
SG - Singapore 1.488
CN - Cina 1.299
BR - Brasile 1.091
SE - Svezia 959
IE - Irlanda 917
DE - Germania 569
UA - Ucraina 398
HK - Hong Kong 393
FI - Finlandia 257
FR - Francia 243
VN - Vietnam 223
GB - Regno Unito 212
IT - Italia 193
CA - Canada 104
IN - India 91
AR - Argentina 58
BD - Bangladesh 47
TR - Turchia 45
PL - Polonia 43
EC - Ecuador 34
IQ - Iraq 34
MX - Messico 33
VE - Venezuela 33
BE - Belgio 29
ZA - Sudafrica 27
JP - Giappone 23
CR - Costa Rica 22
CZ - Repubblica Ceca 20
PK - Pakistan 19
CO - Colombia 17
ID - Indonesia 16
IR - Iran 16
MA - Marocco 16
NL - Olanda 15
UY - Uruguay 14
AT - Austria 13
UZ - Uzbekistan 13
CL - Cile 12
TT - Trinidad e Tobago 12
KE - Kenya 11
NP - Nepal 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
ES - Italia 10
JO - Giordania 10
JM - Giamaica 9
PE - Perù 9
GT - Guatemala 8
HN - Honduras 8
PR - Porto Rico 8
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
IL - Israele 7
MY - Malesia 7
NI - Nicaragua 7
SC - Seychelles 7
SV - El Salvador 7
AL - Albania 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
KZ - Kazakistan 6
LT - Lituania 6
PA - Panama 6
PT - Portogallo 6
PY - Paraguay 6
SA - Arabia Saudita 6
SN - Senegal 6
BG - Bulgaria 5
BO - Bolivia 5
OM - Oman 5
PH - Filippine 5
AU - Australia 4
CH - Svizzera 4
EE - Estonia 4
RO - Romania 4
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
GP - Guadalupe 3
MN - Mongolia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
GR - Grecia 2
GY - Guiana 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
PS - Palestinian Territory 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AM - Armenia 1
Totale 21.418
Città #
Moscow 1.154
Ashburn 1.054
Dublin 917
Jacksonville 852
Singapore 792
Chandler 778
Dallas 629
San Jose 496
Nyköping 456
Beijing 440
Hong Kong 391
Council Bluffs 243
The Dalles 197
Munich 177
Los Angeles 174
Cambridge 150
Princeton 150
Lauterbourg 141
Medford 141
Des Moines 120
Ann Arbor 114
New York 114
Boardman 113
Dearborn 86
Santa Clara 81
São Paulo 74
Ho Chi Minh City 72
Buffalo 70
Helsinki 70
Lancaster 62
Bremen 52
Hanoi 52
Tianjin 51
Shenyang 48
Wilmington 48
Guangzhou 47
Jinan 47
Woodbridge 46
Frankfurt am Main 39
Phoenix 36
Atlanta 35
Turku 34
Redondo Beach 33
Houston 32
Zhengzhou 32
Belo Horizonte 30
Rio de Janeiro 30
Orem 29
Brussels 28
Hebei 28
San Mateo 27
Nanjing 26
Montreal 25
Turin 24
Warsaw 24
San Francisco 23
Boston 22
Denver 22
Newark 22
Pune 22
Taizhou 22
Columbus 21
Haikou 21
Shanghai 21
Chennai 20
Chicago 20
Düsseldorf 20
Hangzhou 20
Johannesburg 20
North Bergen 20
Tokyo 20
Ningbo 19
Ottawa 19
Augusta 18
Brooklyn 18
London 18
Curitiba 17
Poplar 17
Porto Alegre 17
Seattle 17
Brno 16
Mumbai 16
Quito 16
Campinas 15
Rome 15
Stockholm 15
San José 14
Baghdad 13
Brasília 13
Changsha 13
Guayaquil 13
Lanzhou 13
Taiyuan 13
Nanchang 12
Santo André 12
Falls Church 11
Jiaxing 11
Milan 11
Shenzhen 11
Washington 11
Totale 11.971
Nome #
Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis 340
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 322
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 318
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 253
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 251
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 239
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 224
AQP1 in red blood cells of uremic patients during hemodialytic treatment 219
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 217
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 216
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 214
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 212
Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field 208
Aquaporin-2 water channels in spontaneously hypertensive rats 206
Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension 200
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 199
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock 197
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 195
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 195
Are there potential non-lipid-lowering uses of statins in the kidney? 194
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 193
Cardiovascular effects of raloxifene hydrochloride 193
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 193
Does captopril have a direct pro-apoptotic effect? 193
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 192
Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic Acid 191
Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients 187
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 184
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 184
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 184
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 183
Cardiorenal consequences of atherosclerosis and statins therapy: From the past to the future 180
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 179
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 178
A trigonometric approximation method for the monostatic radar cross section 176
Recombinant erythropoietin and hypertension 175
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 174
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. 171
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 171
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 166
Effetti dell'alendronato sul Sister Chromatid Exchanges (SCE) in pazienti con osteoporosi post-menopausale (dati preliminari). 166
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension 164
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 164
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 163
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans 163
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 162
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 161
Oxidative stress and uremia 160
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 158
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 157
Erythropoietin and the brain: from neurodevelopment to neuroprotection 156
Therapy with vasopressin receptor antagonists: the aquaretics 156
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 156
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 155
Increased indexes of thrombin activation in advanced stages of hypertension 155
Effetti di un fitoestrogeno (Genisteina) su marcatori citogenetici in donne in post menopausa. 154
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 153
Statins in the prevention of cardiovascular events in patients with renal failure. 153
Aldosterone and prolactin secretion. II. Plasma renin activity, blood potassium and cortisol levels following administration of sulpiride in normal subjects 153
Statins in nephrotic syndrome: a new weapon against tissue injury. 153
Nonrobertsonian translocation t(6;11) is associated with infertility in an oligoazoospermic male 153
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 152
Effect of unsaturated fatty acids on basal plasma renin activity and afterpostural stimulation 152
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 152
EFFICACY AND TOLERABILITY OF AURANOFIN IN RHEUMATOID-ARTHRITIS - 2 YEARS FOLLOW-UP 152
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 152
ATTIVITÀ RENINICA, ANGIOTENSINA II, ALDOSTERONE PLASMATICI IN SOGGETTI ANZIANI. 151
Statins and progressive renal disease 149
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 148
Cardiovascular remodeling, apoptosis, and drugs 148
The behaviour of serum triiodothyronine in autonomous thyroid nodules and its relationship with the clinical feature 148
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 147
Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy 147
The pleiotropic effects of erythropoietin in the central nervous system 146
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 146
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 145
Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration 144
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration 143
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 140
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 140
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 139
Management of patients after renal graft loss: an open question for nephrologists. 139
Kidney aging: From phenotype to genetics 138
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 135
ELIZABETHAN STUDIES IN ITALY IN 1989 AND 1990 131
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 130
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 130
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 129
Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia 126
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 125
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 122
DOES ERYTHROPOIETIN AUGMENT THE CA2+-MEDIATED K+ FLOW INTO THE RED-BLOOD-CELLS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 121
Recombinant human erythropoietin (rHuEPO): More than just the correction of uremic anemia 118
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 117
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 117
Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits? 116
Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration 114
Flushing due to calcitonin and the opioid system 114
Plasma and erythrocyte magnesium concentrations in essential arterial hypertension 113
Effect of Growth Factors on the Potassium-Calcium induced efflux in vitro in wlole erythrocytes from hypertensive and pregnant subjects with gestation hypertension 111
Totale 16.868
Categoria #
all - tutte 71.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022906 0 0 0 0 62 10 59 39 56 225 133 322
2022/20232.829 203 272 128 221 251 279 25 193 1.107 34 85 31
2023/2024619 48 99 41 58 35 154 26 34 4 35 9 76
2024/20253.105 60 25 46 189 114 132 92 695 762 188 306 496
2025/20268.868 437 650 592 592 661 1.943 1.010 1.137 1.226 326 124 170
2026/20271.894 274 539 448 550 83 0 0 0 0 0 0 0
Totale 21.498